Codexis CDXS 深 沪

Crude Oil Down Over 4%; Verizon Raises Earnings Forecast

Dow up 0.20%, NASDAQ down 0.13%, S&P 500 up 0.04%. Real estate shares up 2.3%. Verizon beats earnings, raises guidance. Equities up/down.

07-25 00:55

Codexis Anticipates Q2 Revenue Of At Least $14.8M

https://www.sec.gov/ix?doc=/Archives/edgar/data/1200375/000119312526314158/d24920d8k.htm

07-24 04:46

Dow Tumbles Over 1%; US Weekly Jobless Claims Fall

U.S. stocks down, Dow falls 500+ points. Energy shares up 0.4%, financial stocks down 1.4%. Jobless claims decline to 213,000, trade deficit shrinks.

03-12 21:49

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers SciSparc (NASDAQ:SPRC) stock rose 35.1% to $5.2 during Thursday's pre-...

03-12 20:05

Preview: Codexis's Earnings

Codexis (NASDAQ:CDXS) is preparing to release its quarterly earnings on Wednesd...

03-11 01:01

Codexis Achieves ISO 9001:2015 Certification

Codexis Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced today that it has earned its ISO 9001:2015 certification. The official certification

02-10 22:11

Earnings Scheduled For November 6, 2025

Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...

2025-11-06 19:12

Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA

2025-05-22 11:00

Codexis to Participate in Jefferies Global Healthcare Conference

Codexis to attend Jefferies Global Healthcare Conference on June 3-5, 2025, with management participating in a fireside chat on June 4 at 3:10 pm ET. A live webcast and 90-day replay will be available on the company’s Investor Relations website.

2025-05-21 20:05

Cantor Fitzgerald Reiterates Overweight on Codexis, Maintains $11 Price Target

Cantor Fitzgerald analyst Kristen Kluska reiterates Codexis (NASDAQ:CDXS) with a Overweight and maintains $11 price target.

2024-09-21 00:03